Companies Abcodia

Detecting ovarian cancer  early


Abcodia was looking to commercialise a novel biomarker-based screening procedure to detect ovarian cancer at an earlier stage.

The company was sold to GENinCode in 2022.

Cambridge Innovation Capital is a leading Series A investor in the Cambridge ecosystem.

We were born out of a unique relationship with the University of Cambridge and we maintain privileged access to its most inspiring ideas and people in life sciences and deep tech.

Discover more


Read More